A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

Prepared off-label from commercially available intravenous products. NA: Not available. Cystic fibrosis (CF) pulmonary disease is characterized by chronic and recurrent infection, and airway ...